Applying low coverage whole genome sequencing to detect malignant ovarian mass
Abstract To evaluate whether low coverage whole genome sequencing is suitable for the detection of malignant pelvic mass and compare its diagnostic value with traditional tumor markers. We enrolled 63 patients with a pelvic mass suspicious for ovarian malignancy. Each patient underwent low coverage...
Main Authors: | Ming Chen, Pengqiang Zhong, Mengzhi Hong, Jinfeng Tan, Xuegao Yu, Hao Huang, Juan Ouyang, Xiaoping Lin, Peisong Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-08-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-021-03046-3 |
Similar Items
-
Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective, Multicentre Trial
by: Vincent Dochez, et al.
Published: (2019-10-01) -
Low serum T3 levels are associated with false-positive results when using the risk of ovarian malignancy algorithm (ROMA) in women with benign ovarian disease
by: Haeil Park, et al.
Published: (2021-01-01) -
An Update on Ovarian Aging and Ovarian Reserve Tests
by: Ramazan Amanvermez, et al.
Published: (2016-01-01) -
Clinical value of ROMA index in diagnosis of ovarian cancer: meta-analysis
by: Cui RL, et al.
Published: (2019-03-01) -
A novel EIF4ENIF1 mutation associated with a diminished ovarian reserve and premature ovarian insufficiency identified by whole-exome sequencing
by: Minying Zhao, et al.
Published: (2019-12-01)